Navigation Links
New nano-canary in the nanotoxicology coalmine: The body itself

There is growing consensus among scientists, regulators, politicians, industry and the public that we need to know more about the possible harmful or adverse effects of nanoparticles on human health.

Likewise, most agree that these incredibly small materials can behave quite differently from conventional materials. Nonetheless, neighborhood stores feature products that promise benefits from these near-atomic level materials, from paints and cosmetics to toothpaste and sunscreens. But, could we be putting human health at risk by exposing consumers to potentially toxic materials?

To investigate the damage potential of sub-micron sized particles, S.K. Sundaram and Thomas J. Weber, scientists at the Department of Energy's Pacific Northwest National Laboratory in Richland, Wash., have harnessed living cells to monitor responses to a variety of biologically active test agents. They presented their findings Friday at the American Association for the Advancement of Science annual meeting.

"Our process requires that live cells be grown on an infrared transparent substrate giving us an opportunity to closely examine the biological effects in living cells," said Sundaram. Live cell Fourier transform infrared, FTIR, spectroscopy offers several attractive features for these investigations. These include the potential to detect biologically active nanoparticles without any prior knowledge of cell signaling pathways affected by them or need of a contrast agent to detect the biological response. Thus, live cell FTIR spectroscopy is expected to be a sentinel of exposure to help identify the physico-chemico properties of nanoparticles that mediate biological activity, without bias of what that biological activity represents.

The PNNL scientists are also developing infrared transparent chemistries that are expected to improve FTIR measurements in live cell experiments. "We believe this report outlines the first use of FTIR spectroscopy to exami
'"/>

Source:DOE/Pacific Northwest National Laboratory


Page: 1 2

Related biology news :

1. A bathroom that cleans itself
2. New stem-cell findings can help the body to cure itself
3. Smart genetic therapy helps the body to heal itself
4. No carrier necessary: This drug delivers itself

Post Your Comments:
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/5/2009)... been awarded a training grant in the amount of $2...its Integrative Graduation Education and Research ...grant to be awarded to Kent State. The grant, whic...stment Act of 2009, runs through 2014. , The gra...ent aquatic resource sensing (EARS). The purpose o...
(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3
...ids are synthetic hormones derived from the human ... been suspected in professional baseball and other...n endurance, is paramount. Power lifting is such a...act of anabolic steroid use on power lifters years...The researchers found that while physical traces o...
...udget was launched simultaneously by Global Carbon... Paris Observatory, and in the USA at Capitol Hill...l. , The Global Carbon Project posted the most re...to understanding the balance of carbon added to th...imate change. Despite the increasing international...
..., 2008 -Microbiologically contaminated water plagu...eri-urban populations in developing countries. Rou...nking water die each year from the consumption of ...5 years of age. , A new article published in Cu... instructions for constructing and using low-cost ...
Other Biology News:Anabolic steroids provide a competitive edge in power lifting years after doping has ended 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 3Growth in the global carbon budget 2
(Date:11/5/2009)...ovember 5, 2009 at 4:30 p.m. Eastern Time , B...all/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex...d unaudited financial results for the third quarte...iewed the Company,s highlights for the third quart...ts reflect the operations of OncoGenex Technologie...
(Date:11/5/2009)...ewswire-FirstCall/ -- Wound Management Technologie...ed into a Letter of Intent to purchase all healthc... Inc. (OTC Bulletin Board: VHGI). The deal provide... 4,000,000 shares of WNDM and a royalty agreement ...chnology being acquired from VHGI. WNDM closed a...
(Date:11/5/2009).... 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Co..."Company") today announced,that the Company plans ...,Monday, November 9, 2009, after the market closes...ll at 5:00 pm ET on November 9, 2009,to discuss th...e call by,dialing 1-888-713-4211 or 1-617-213-4864...
(Date:11/4/2009)...ar, which will be presented on November 19 and is ...hemistry processing, will deal with the applicatio...so and micro scale flow chemistry equipment. Prof... recognized with several prestigious prizes and aw... Prize. , Columbia, MD (P...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BMP Sunstone to Report Third Quarter 2009 Financial Results 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...Presented at American Society for Metabolic and Ba...ting, SAN CLEMENTE, Calif., June 23 USGI Medical...presented clinical evidence showing,that its EndoS...s and,physicians to use an incisionless technique ...in patients who,ve regained weight after initial,s...
...PRING, Md. and SOUTH SAN FRANCISCO, Calif., June 2...d Actelion,Pharmaceuticals US, Inc. today announce...l PHA Award of Excellence in Pulmonary Arterial,Hy... $50,000, will be,awarded to an institution of Dr....llence in care for patients with PAH. The award, s...
...ion to enhance industry leader,s dermatological po...oratories Inc.,the world,s largest independent pha...oday announced it has signed a definitive merger a...ll acquire Barrier Therapeutics,Inc. ("Barrier The...ransaction, a tender offer followed by a merger of...
Other Biology Technology:Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 2Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 2Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 3Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 4Barrier Therapeutics to Merge Into Stiefel Laboratories 2Barrier Therapeutics to Merge Into Stiefel Laboratories 3Barrier Therapeutics to Merge Into Stiefel Laboratories 4Barrier Therapeutics to Merge Into Stiefel Laboratories 5
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Biology Products: